Market Cap 266.49M
Revenue (ttm) 198.77M
Net Income (ttm) -18.90M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -9.51%
Debt to Equity Ratio 0.00
Volume 340,300
Avg Vol 484,748
Day's Range N/A - N/A
Shares Out 59.09M
Stochastic %K 82%
Beta 0.72
Analysts Sell
Price Target $12.67

Company Profile

Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide. The company's marketed products include HETLIOZ to treat non-24-hour sleep-wake disorders; Fanapt (iloperidone) for the treatment of bipolar I disorder and Parkinson's disease psychosis, as well as a long acting injectable (LAI) formulation to treat schizophrenia; and Ponvory for the treatment of psoriasis and ulcerative colitis. It...

Industry: Biotechnology
Sector: Healthcare
Phone: 202 734 3400
Fax: 202 296 1450
Address:
2200 Pennsylvania Avenue NW, Suite 300E, Washington, United States
HorizonBull
HorizonBull Aug. 22 at 2:30 PM
$VNDA so undervalue. worth now 10+
0 · Reply
StocktwitsNews
StocktwitsNews Aug. 22 at 2:44 AM
Retail Buzz Builds As Vanda Urges FDA Chief To Revisit Hetlioz Generics Decision — Alleges “Bias Toward Approvals” $VNDA https://stocktwits.com/news/equity/markets/retail-buzz-builds-as-vanda-urges-fda-chief-to-revisit-hetlioz-generics-decision-alleges-bias-toward-approvals/chsmF1DRdiD
0 · Reply
Texout
Texout Aug. 21 at 5:38 PM
$VNDA added 8k shares today
0 · Reply
Texout
Texout Aug. 21 at 2:06 PM
$VNDA when you witnessed dodgy bank lending standards nearly break the entire financial system in 08’ it is hard not to understand that any macro weakness is generally bad for assets, most profoundly expressed in stock prices of course. Not here- any macro weakness simply implies even cheaper entry points for an already mispriced and underappreciated asset. I am loading more
0 · Reply
prismmarketview
prismmarketview Aug. 21 at 1:54 PM
(NASDAQ: $VNDA) Vanda Pharma wins big as the U.S. Court of Appeals overturns the FDA’s jet lag drug rejection. HETLIOZ® could become the first approved jet lag treatment, unlocking a major new market. https://prismmarketview.com/vanda-scores-major-court-victory-against-fda-paving-path-for-jet-lag-treatment/
0 · Reply
Texout
Texout Aug. 21 at 1:06 PM
$VNDA this should currently be trading at 10$ not 4,60. if they manage to grow to 750mm revenue with their broader psychiatry product line by 2030 this will be trading 40-50$ at a minimum. I get that people don’t like the ad spend and I am not a fan either but at 4,60 I remain bid, I mean strongly bid. Crossed 350k share holding and will be growing.
1 · Reply
JarvisFlow
JarvisFlow Aug. 21 at 11:30 AM
HC Wainwright & Co. has updated their rating for Vanda Pharmaceuticals ( $VNDA ) to Buy with a price target of 20.
1 · Reply
Texout
Texout Aug. 20 at 4:31 PM
$VNDA added 5k might do more
0 · Reply
Texout
Texout Aug. 20 at 4:25 PM
$VNDA adding.
0 · Reply
Texout
Texout Aug. 19 at 3:55 PM
$VNDA adding 10k
0 · Reply
Latest News on VNDA
Cycle Pharma maintains takeover offer for Vanda Pharmaceuticals

Oct 14, 2024, 10:37 AM EDT - 11 months ago

Cycle Pharma maintains takeover offer for Vanda Pharmaceuticals


U.S. FDA declines to approve Vanda's stomach paralysis drug

Sep 19, 2024, 7:57 AM EDT - 1 year ago

U.S. FDA declines to approve Vanda's stomach paralysis drug


HorizonBull
HorizonBull Aug. 22 at 2:30 PM
$VNDA so undervalue. worth now 10+
0 · Reply
StocktwitsNews
StocktwitsNews Aug. 22 at 2:44 AM
Retail Buzz Builds As Vanda Urges FDA Chief To Revisit Hetlioz Generics Decision — Alleges “Bias Toward Approvals” $VNDA https://stocktwits.com/news/equity/markets/retail-buzz-builds-as-vanda-urges-fda-chief-to-revisit-hetlioz-generics-decision-alleges-bias-toward-approvals/chsmF1DRdiD
0 · Reply
Texout
Texout Aug. 21 at 5:38 PM
$VNDA added 8k shares today
0 · Reply
Texout
Texout Aug. 21 at 2:06 PM
$VNDA when you witnessed dodgy bank lending standards nearly break the entire financial system in 08’ it is hard not to understand that any macro weakness is generally bad for assets, most profoundly expressed in stock prices of course. Not here- any macro weakness simply implies even cheaper entry points for an already mispriced and underappreciated asset. I am loading more
0 · Reply
prismmarketview
prismmarketview Aug. 21 at 1:54 PM
(NASDAQ: $VNDA) Vanda Pharma wins big as the U.S. Court of Appeals overturns the FDA’s jet lag drug rejection. HETLIOZ® could become the first approved jet lag treatment, unlocking a major new market. https://prismmarketview.com/vanda-scores-major-court-victory-against-fda-paving-path-for-jet-lag-treatment/
0 · Reply
Texout
Texout Aug. 21 at 1:06 PM
$VNDA this should currently be trading at 10$ not 4,60. if they manage to grow to 750mm revenue with their broader psychiatry product line by 2030 this will be trading 40-50$ at a minimum. I get that people don’t like the ad spend and I am not a fan either but at 4,60 I remain bid, I mean strongly bid. Crossed 350k share holding and will be growing.
1 · Reply
JarvisFlow
JarvisFlow Aug. 21 at 11:30 AM
HC Wainwright & Co. has updated their rating for Vanda Pharmaceuticals ( $VNDA ) to Buy with a price target of 20.
1 · Reply
Texout
Texout Aug. 20 at 4:31 PM
$VNDA added 5k might do more
0 · Reply
Texout
Texout Aug. 20 at 4:25 PM
$VNDA adding.
0 · Reply
Texout
Texout Aug. 19 at 3:55 PM
$VNDA adding 10k
0 · Reply
Trendrebel
Trendrebel Aug. 19 at 2:48 PM
$VNDA Wobble around the MA50 - and the Fibo 61,8% again. Last time it didn´t hold for long. Lets see this time. Might be the catalyst to complete left shoulder in the inverse SHS
0 · Reply
HorizonBull
HorizonBull Aug. 19 at 1:55 PM
$VNDA Be ready for another BO
1 · Reply
mciuzelis
mciuzelis Aug. 19 at 8:39 AM
$VNDA as a reminder what was put on a table and rejected by the Board.
1 · Reply
Trendrebel
Trendrebel Aug. 19 at 5:58 AM
$VNDA It´s incredible how loyal this follow the sign of a looming Inverse SHS. I didn´t touch the trendlines since it made the top of the head. That tells me, that inst. are in full control here. Extended fibonacci levels are following: 50%=4,80. 61,6%=4.95. 100%=5.13. 5,13 is EXACTLY the shoulder. So... Any break and confirmation of 5.13 is a huge buy signal what might send it to test 5.95 & 6.77 ( top of fibonacci ).
1 · Reply
HFlier
HFlier Aug. 18 at 8:55 PM
$VNDA Based on todays price action, it looks like some people wanted out at their break even.
1 · Reply
10sense
10sense Aug. 18 at 7:24 PM
$VNDA I think a real buyout should come pretty quickly at least I hope so
1 · Reply
HorizonBull
HorizonBull Aug. 18 at 7:19 PM
$VNDA loaded 4k 4.62
1 · Reply
maplelakeduckslayer
maplelakeduckslayer Aug. 18 at 7:02 PM
$VNDA been slowly building a swing position here and suddenly today after this news...you can't place an electronic buy with Schwab you have to call. I've seen this on like the China scams before but not allowing buy orders on a company like this is pretty ridiculous and fishy They'll let you buy a penny stock scam diluting like crazy and up 1000% on the day but not this?
0 · Reply
LoveRetailFroth
LoveRetailFroth Aug. 18 at 6:32 PM
$VNDA Finally some movement. Holding it over a yr! Let’s go $20🚀
0 · Reply
JazzyJ03
JazzyJ03 Aug. 18 at 4:38 PM
0 · Reply
StocktwitsNews
StocktwitsNews Aug. 18 at 4:02 PM
Vanda Pharma Stock Rockets 9% After Federal Appeals Court Sets Aside FDA Action: Retail Expects Stock To Cross $5-Mark $VNDA $IWMW $AVUS https://stocktwits.com/news/equity/markets/vanda-pharma-stock-rallies-after-federal-appeals-court-sets-aside-fda-action/chsOi7vRdXQ
0 · Reply
pablo4
pablo4 Aug. 18 at 3:52 PM
$VNDA Has any bio, even the big boys, ever challenged the FDA in court with regard to its authority to not approve a drug for any reason? From what I can tell, the is a first. VNDA went to court to basically say the FDA had no authority to deny its drug approval because it violated its own protocols offering VNDA the chance for a hearing. I wonder how many other bios have had been denied hearings over the years.....my guess is many times it has happened. If the FDA didn't want to fool with justifying itself, I guess it just used its power to blow you off. Well, VNDA, by winning its case, opened the door for many other companies to have their drugs more carefully reviewed in the future is my bet. VNDA's victory becomes a legal precedent under common law. I suppose if the FDA wanted to go to the Supreme Court on appeal, it could....but I don't think it will want to embarrass itself further. JMO. I think this is a big deal for VNDA and its shareholders. IMO
0 · Reply